117 related articles for article (PubMed ID: 1926886)
1. Effect of a sensitive thyrotropin-stimulating hormone assay on dosing of L-thyroxine.
Drinka P; Schomisch G; Depka C; Deterville R; Nickel D; Voeks S
Wis Med J; 1991 Aug; 90(8):468-9. PubMed ID: 1926886
[TBL] [Abstract][Full Text] [Related]
2. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
3. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
4. Use of a sensitive thyrotropin assay for monitoring treatment with levothyroxine.
Watts NB
Arch Intern Med; 1989 Feb; 149(2):309-12. PubMed ID: 2644903
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin (TSH) secretion in L-thyroxine treated children: assessment by a ultrasensitive TSH immunoradiometric assay.
Radetti G; Pasquino B; Franzellin F; Mengarda G
Helv Paediatr Acta; 1987 Jun; 42(5-6):413-8. PubMed ID: 3136099
[TBL] [Abstract][Full Text] [Related]
6. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.
Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
Br J Gen Pract; 1993 Mar; 43(368):107-9. PubMed ID: 8323787
[TBL] [Abstract][Full Text] [Related]
7. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
10. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function.
Nuutila P; Irjala K; Viikari J; Prinssi VP; Kaihola HL
Ann Clin Res; 1988; 20(3):158-63. PubMed ID: 3195979
[TBL] [Abstract][Full Text] [Related]
12. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.
De Whalley P
Br J Gen Pract; 1995 Feb; 45(391):93-5. PubMed ID: 7702890
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
15. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay.
Escalante DA; Arem N; Arem R
Am J Med; 1995 Apr; 98(4):374-8. PubMed ID: 7709950
[TBL] [Abstract][Full Text] [Related]
16. Low but detectable serum thyroid-stimulating hormone concentrations in ambulant subjects not receiving thyroxine.
Chatterjee S; O'Malley BP; Price DE; Fielding AM; Aitken R
Ann Clin Biochem; 2003 Nov; 40(Pt 6):639-42. PubMed ID: 14629801
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
[TBL] [Abstract][Full Text] [Related]
18. [The interpretation of the thyroid stimulating hormone (TSH) assay].
Wiersinga WM
Ned Tijdschr Geneeskd; 2003 Jun; 147(24):1156-8. PubMed ID: 12845833
[TBL] [Abstract][Full Text] [Related]
19. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM
Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
[TBL] [Abstract][Full Text] [Related]
20. [The effect of three kinds of thyroid hormone preparations on serum thyroid hormone and TSH in primary hypothyroidism].
Dai W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Dec; 12(6):421-4. PubMed ID: 2151260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
